26 results
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... if MIC<0.12 ug/ml ... #IDSA #Prevention ... opportunistic #infections #HIVAIDS ... #pharmacology
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
antimicrobial therapy in bacterial ... #IDSA #Meningitis ... #Antibiotics #Antimicrobial ... InfectiousDiseases #Pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... HumanPapillomavirus #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
Antibiogram - Antibiotic Resistance Table for Severe Multidrug Resistant Bacteria

ESBL Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae
MDR Pseudomonas Aeruginosa
Carbapenem-Resistant Acinetobacter

Adapted from
Antibiogram - Antibiotic ... Multidrug Resistant Bacteria ... #Antibiogram #Antibiotic ... InfectiousDiseases #Resistant #Comparison ... #Table #Pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... Trypanosomiasis #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... #Encephalitis #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... Castleman’s Disease (MCD ... KaposiSarcoma #Castlemans #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... Leishmaniasis #Prevention ... opportunistic #infections #HIVAIDS ... #pharmacology